Viveve Medical (NASDAQ:VIVE) announced its earnings results on Thursday. The company reported ($0.37) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.38) by $0.01, Bloomberg Earnings reports. Viveve Medical had a negative return on equity of 437.98% and a negative net margin of 269.24%. The company had revenue of $5.53 million for the quarter, compared to analyst estimates of $4.97 million.
Shares of Viveve Medical traded up $0.12, reaching $2.59, during trading on Friday, according to Marketbeat Ratings. The company’s stock had a trading volume of 5,067 shares, compared to its average volume of 216,666. Viveve Medical has a twelve month low of $1.60 and a twelve month high of $7.25. The company has a quick ratio of 6.00, a current ratio of 6.47 and a debt-to-equity ratio of 1.55. The firm has a market cap of $73.48 million, a price-to-earnings ratio of -1.23 and a beta of -0.53.
A number of brokerages have issued reports on VIVE. ValuEngine lowered Viveve Medical from a “buy” rating to a “hold” rating in a research report on Monday, July 30th. Craig Hallum lowered Viveve Medical from a “buy” rating to a “hold” rating in a research report on Friday, May 11th. Finally, Stifel Nicolaus began coverage on Viveve Medical in a research report on Tuesday, April 17th. They issued a “buy” rating and a $6.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $9.20.
Viveve Medical Company Profile
Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.
Featured Story: Do closed-end mutual funds pay dividends?
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.